Old Web
English
Sign In
Acemap
>
authorDetail
>
Andrew Nicklawsky
Andrew Nicklawsky
Anschutz Medical Campus
Medicine
Cancer research
Renal cell carcinoma
Oncology
Internal medicine
4
Papers
3
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Comparative effectiveness of combination first-line therapies for metastatic renal cell carcinoma (mRCC).
2021
Journal of Clinical Oncology
Rebecca C. Shay
Andrew Nicklawsky
Elaine Tat Lam
Show All
Source
Cite
Save
Citations (0)
Differences in TCR repertoire and T cell activation underlie the divergent outcomes of antitumor immune responses in tumor-eradicating versus tumor-progressing hosts.
2021
Journal for ImmunoTherapy of Cancer
Rachel A. Woolaver
Xiaoguang Wang
Alexandra L. Krinsky
Brittany C. Waschke
Samantha M. Y. Chen
Vince Popolizio
Andrew Nicklawsky
Dexiang Gao
Zhangguo Chen
Antonio Jimeno
Xiao-Jing Wang
Jing Hong Wang
Show All
Source
Cite
Save
Citations (1)
A Cost-Effectiveness Analysis of Nivolumab plus Ipilimumab Versus Pembrolizumab plus Axitinib and Versus Avelumab plus Axitinib in First-Line Treatment of Advanced Renal Cell Carcinoma
2021
Clinical Genitourinary Cancer
Rebecca C. Shay
Andrew Nicklawsky
Dexiang Gao
Elaine T. Lam
Show All
Source
Cite
Save
Citations (2)
Effect of continuing osimertinib with chemotherapy in the post-progression setting on progression-free survival among patients with metastatic epidermal growth factor receptor (EGFR) positive non-small cell lung cancer.
2021
Journal of Clinical Oncology
Tejas Patil
David Chun Cheong Tsui
Andrew Nicklawsky
Erin L. Schenk
William T. Purcell
Paul A. Bunn
Jose Maria Pacheco
D. Ross Camidge
Show All
Source
Cite
Save
Citations (0)
1